The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback